- Trials with a EudraCT protocol (6,671)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
6,671 result(s) found.
Displaying page 1 of 334.
EudraCT Number: 2019-003461-17 | Sponsor Protocol Number: 71272 | Start Date*: 2020-01-07 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF) | ||
Medical condition: Heart failure with preserved ejection fraction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002078-30 | Sponsor Protocol Number: NL70122.078.20 | Start Date*: 2020-06-19 |
Sponsor Name:Erasmus MC | ||
Full Title: Autoimmune epilepsy Modulated by IVIg – effects on Cortical Excitability, the AMICE study | ||
Medical condition: Auto-immune epilepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001722-25 | Sponsor Protocol Number: ZonMw80-83600-98-10226 | Start Date*: 2013-08-27 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: Cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson’s disease: a multi-center placebo-controlled trial (CHEVAL) | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014922-40 | Sponsor Protocol Number: PT-171-503 | Start Date*: 2010-07-07 |
Sponsor Name:Erasmus MC | ||
Full Title: Carfilzomib in combination with Thalidomide and Dexamethasone for remission induction and consolidation of Multiple Myeloma at first presentation | ||
Medical condition: Multiple myeloma at first presentation | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004108-20 | Sponsor Protocol Number: UMCN-AKF13.05 | Start Date*: 2014-03-17 | ||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | ||||||||||||||||||
Full Title: Improving the tolerability of the oral targeted anti-cancer drug pazopanib by food intake (DIET) | ||||||||||||||||||
Medical condition: Patients who are treated or will be treated with pazopanib. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000724-10 | Sponsor Protocol Number: 60978 | Start Date*: 2018-07-04 |
Sponsor Name:Academic Medical Center | ||
Full Title: Targeting esophageal cancer with HDL nanoparticles: an imaging study | ||
Medical condition: Primary esophageal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001853-41 | Sponsor Protocol Number: 57698 | Start Date*: 2018-09-19 | ||||||||||||||||||||||||||
Sponsor Name:Academic Medical Center | ||||||||||||||||||||||||||||
Full Title: Intensive endoscopic therapy versus conventional treatment for untreated benign anastomotic strictures after esophagectomy: a pilot and randomized controlled trial | ||||||||||||||||||||||||||||
Medical condition: Benign esophagogastric anastomotic strictures after esophagectomy | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002209-39 | Sponsor Protocol Number: M14LTK | Start Date*: 2014-07-30 |
Sponsor Name:The Netherlands Cancer Institute | ||
Full Title: Phase I/II study with lapatinib plus trametinib in patients with metastatic KRAS mutant non-small cell lungcancer | ||
Medical condition: non-small cell lung cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004053-76 | Sponsor Protocol Number: NL73102.018.20 | Start Date*: 2020-12-10 |
Sponsor Name:Amsterdam UMC [...] | ||
Full Title: Effectiveness of methylphenidate in children and adults with Smith Magenis syndrome and attention-deficit/hyperactivity disorder: An N-of-1 series | ||
Medical condition: Smith Magenis syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005083-34 | Sponsor Protocol Number: CAPI2017NL10 | Start Date*: 2017-08-23 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: Conestat alfa as prophylactic treatment for idiopathic non-histaminergic acquired angioedema | ||
Medical condition: The medical condition to be investigated is idiopathic non-histaminergic angioedema (InH-AAE). This disease is characterized by recurrent episodes with swelling of the subcutis and mucous membranes... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002691-27 | Sponsor Protocol Number: 690550 | Start Date*: 2017-10-19 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: An open label exploratory analysis of the histological, immunological and microbiome changes of the colonic mucosa during treatment with tofacitinib for moderate-severe ulcerative colitis | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001440-18 | Sponsor Protocol Number: IACI2016 | Start Date*: 2018-05-30 |
Sponsor Name:university medical center utrecht | ||
Full Title: Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls | ||
Medical condition: cystic fibrosis and healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000238-23 | Sponsor Protocol Number: ExeBAT01 | Start Date*: 2016-08-09 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Exenatide on brown adipose tissue activity and energy expenditure in healthy young men | ||
Medical condition: Healthy volunteers, intended indications: obesity and dyslipidemia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001006-34 | Sponsor Protocol Number: 2015C104 | Start Date*: 2016-10-25 |
Sponsor Name:University Medical Centre Groningen (UMCG) | ||
Full Title: Groningen Intervention study for the Preservation of cardiac function with sodium thiosulfate after ST-segment elevation myocardial infarction | ||
Medical condition: ST-segment elevated myocardial infarction, decompensatio cordis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005527-12 | Sponsor Protocol Number: 55868 | Start Date*: 2016-12-02 |
Sponsor Name: | ||
Full Title: Sirolimus for the treatment of severe intestinal polyposis in patients with familial adenomatous polyposis (FAP); a pilot study | ||
Medical condition: Familial adenomatous polyposis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002743-26 | Sponsor Protocol Number: 2019PA01 | Start Date*: 2020-02-04 |
Sponsor Name:Paulien van Deutekom Foundation | ||
Full Title: Pembrolizumab alone versus pembrolizumab-chemotherapy in first line NSCLC | ||
Medical condition: non small cell lung cancer (NSCLC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003820-22 | Sponsor Protocol Number: 2016-Longterm-OX | Start Date*: 2016-12-22 | |||||||||||
Sponsor Name:Dutch Growth Research Foundation | |||||||||||||
Full Title: Intranasal administration of oxytocin in children with Prader-Willi Syndrome. A randomized, open-label, cross-over trial of different treatment regimens of oxytocin administration. Effects on eatin... | |||||||||||||
Medical condition: Prader-Willi syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Not Authorised) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002183-41 | Sponsor Protocol Number: METc2017.174 | Start Date*: 2020-08-27 |
Sponsor Name:UMCG | ||
Full Title: PET for Registration of Inflammation in the Vascular wall of Intracranial Aneurysms | ||
Medical condition: intracranial aneurysm | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004745-70 | Sponsor Protocol Number: 55438 | Start Date*: 2018-11-06 |
Sponsor Name:Academic Medical Center (AMC) | ||
Full Title: Efficacy of intranasal ketamine on acute suicidality, a double blind randomized placebo-controlled trial (Ketamine Trial Amsterdam, KETA) | ||
Medical condition: Acute suicidality, which is a rapid increase in suicidal ideation or behaviour from the patient's 'baseline' in the last 24 hours. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004486-37 | Sponsor Protocol Number: 59812 | Start Date*: 2017-09-19 | ||||||||||||||||
Sponsor Name:University Medical Centre Utrecht | ||||||||||||||||||
Full Title: FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment | ||||||||||||||||||
Medical condition: Acute febrile urinary tract infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.